PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Neutron Scattering Division, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, TN 37831, USA; National Virtual Biotechnology Laboratory, US Department of Energy, Washington, DC, USA.\', \'National Virtual Biotechnology Laboratory, US Department of Energy, Washington, DC, USA; Biosciences Division, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, TN 37831, USA.\', \'National Virtual Biotechnology Laboratory, US Department of Energy, Washington, DC, USA; Second Target Station, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, TN 37831, USA. Electronic address: coatesl@ornl.gov.\', \'Neutron Scattering Division, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, TN 37831, USA; National Virtual Biotechnology Laboratory, US Department of Energy, Washington, DC, USA. Electronic address: kovalevskyay@ornl.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0969-2126(20)30379-810.1016/j.str.2020.10.007
?:doi
?:hasPublicationType
?:journal
  • Structure (London, England : 1993)
is ?:pmid of
?:pmid
?:pmid
  • 33152262
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all